prednisone has been researched along with Triple Negative Breast Neoplasms in 2 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Younce, CM | 1 |
| Lawton, JM | 1 |
| Patel, DR | 1 |
| Bonnefoi, H | 1 |
| Grellety, T | 1 |
| Tredan, O | 1 |
| Saghatchian, M | 1 |
| Dalenc, F | 1 |
| Mailliez, A | 1 |
| L'Haridon, T | 1 |
| Cottu, P | 1 |
| Abadie-Lacourtoisie, S | 1 |
| You, B | 1 |
| Mousseau, M | 1 |
| Dauba, J | 1 |
| Del Piano, F | 1 |
| Desmoulins, I | 1 |
| Coussy, F | 1 |
| Madranges, N | 1 |
| Grenier, J | 1 |
| Bidard, FC | 1 |
| Proudhon, C | 1 |
| MacGrogan, G | 1 |
| Orsini, C | 1 |
| Pulido, M | 1 |
| Gonçalves, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Trial Evaluating the Activity of Abiraterone Acetate Plus Prednisone in Patients With a Molecular Apocrine HER2-negative Locally Advanced or Metastatic Breast Cancer[NCT01842321] | Phase 2 | 34 participants (Actual) | Interventional | 2013-07-31 | Completed | ||
| PAveMenT: Phase Ib Study of Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer[NCT04360941] | Phase 1 | 45 participants (Anticipated) | Interventional | 2020-08-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for prednisone and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Diseas | 2016 |
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Diseas | 2016 |
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Diseas | 2016 |
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Diseas | 2016 |
1 other study available for prednisone and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Atezolizumab-induced hemolytic anemia - A case report.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemothera | 2021 |